SCP
MED icon

Steamboat Capital Partners’s Medifast MED Stock Holding History

Steamboat Capital Partners’s Portfolio MED Stock Details MED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$7.5M Sell
706,699
-891
-0.1% -$10.3K 1.6% 27
2026
Q1 		$7.21M Buy
707,590
+431,176
+156% +$4.65M 1.79% 25
2025
Q4 		$2.95M Buy
+276,414
New +$3.31M 0.81% 40

Other funds holding MED

Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

Steamboat Capital Partners's MED Position: Q2 2026 in Review

Steamboat Capital Partners reduced its Medifast (MED) stake by 0.13% in Q2 2026, selling an estimated $10.3K and leaving 706,699 shares worth $7.5M. The position accounts for 1.6% of the portfolio, ranked #27.

Steamboat Capital Partners first reported a position in MED in Q4 2025 and has held it in 3 quarters since. 113 funds tracked by Wall St. Rank hold MED as of Q2 2026.

  • Steamboat Capital Partners held 706,699 shares of Medifast worth $7.5M as of Q2 2026.
  • Steamboat Capital Partners sold 891 Medifast shares in Q2 2026, an estimated $10.3K.
  • Medifast made up 1.6% of Steamboat Capital Partners's portfolio in Q2 2026, its #27 holding.
  • Steamboat Capital Partners first reported a position in Medifast in Q4 2025 and has held it in 3 quarters since.
  • 113 funds tracked by Wall St. Rank held Medifast as of Q2 2026.

Based on Steamboat Capital Partners's 13F filing for Q2 2026, filed 14 Aug 2026.